Attending #ESMO24 in Barcelona from September 13-17? Our Medical Affairs team welcomes physicians to connect and explore the future of immuno-oncology. Schedule a meeting here: https://lnkd.in/gymm3V-Y
Über uns
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA. For more information, visit www.agenusbio.com or follow us at @agenus_bio. Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/
- Website
-
https://agenusbio.com/.
External link for Agenus
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 201-500 Mitarbeiter
- Hauptsitz
- Lexington, Massachusetts
- Typ
- Öffentliches Unternehmen
- Gegründet
- 1994
- Spezialitäten
- Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors and Modulators, Immunotherapy, Cell therapy, Antibodies, and GMP Manufacturing
Standorte
-
Primäre
Wegbeschreibung erhalten
3 Forbes Road
Lexington, Massachusetts 02421, US
Employees at Agenus
Aktualisierungen
-
Andrew Wortmann, Creative Director at Fight Colorectal Cancer, emphasizes the urgent need for new therapies for the 95% of colorectal cancer patients with MSS disease. Driving innovation and developing new treatment options are essential for individuals living with colorectal cancer.
-
Michael Sapienza, CEO of Colorectal Cancer Alliance, highlights the urgent need for new treatments to tackle MSS colorectal cancer. Together, we are committed to driving change and innovation to bring hope to patients living with CRC.
-
-
Today we released our Q2 2024 operational and financial results - get the latest here: https://lnkd.in/eCYSH_j6
-
We are pleased to announce the publication of our latest study in Cancer Discovery (AACR Journals) exploring botensilimab’s mechanism of action and potential in addressing various treatment-resistant cancers. Learn more: https://lnkd.in/ecczYB9F #CancerResearch #Immunotherapy #CancerTreatment
-
How is #immunotherapy different? Swipe to discover the benefits compared to traditional cancer treatments.
-
Our own Nils Eckardt MD MSc shares his perspectives on driving change in #oncology via OncoDaily. Watch here: https://lnkd.in/ekEi65Uv
Driving Change in Oncology: the Vision of the Chief Medical Affairs Officer of Agenus
https://www.youtube.com/
-
Colorectal cancer is the second leading cause of cancer death in the United States. Marianne Pearson, Senior Director of Patient Navigation at Colorectal Cancer Alliance, highlights the urgent need for innovative treatment options for these patients.
-
Our own Dr. Benny Johnson shares his journey from medical oncologist to caregiver for his wife battling colorectal cancer with OncoDaily. Discover his insights on balancing professional expertise with personal care, and the hope found in innovative treatments. Read the full article here: https://bit.ly/3WyCcXz